Technologies, Applications and Regulatory barriers for Bioprinting and 3D printing in the Life Sciences

Held in conjunction with Bioprinting & 3D Printing in the Life Sciences

20 Jul 2016, at 09:00-12:30 in Singapore

Technologies, Applications and Regulatory barriers for Bioprinting and 3D printing in the Life Sciences
20 Jul 2016, 9.00-12.30pm 

This pre-event training course will cover the process flows of 3D-printing and bioprinting, highlighting the similarity and differences between them in terms of machine, materials and processes. 

We provide various examples to illustrate value-capturing of 3D printing and bioprinting technology as they are being applied successfully in biomedical, tissue engineering, devices and etc. 

We also discuss companies who are actively commercializing bioprinting technologies (software, machines and materials). Regulatory barriers to implement this technology will also be presented. 

This is a must-attend course for researchers from academic institutions as well as companies seeking a hands-on understanding of the 3D-Bioprinting and 3D printing for the future of life sciences. 

We will cover 

• Introduction to Bioprinting 
• Commercial landscape of bioprinting  
• Bioprinting vs 3D printing: Fantasy and reality 
• Techniques and materials of bioprinting and 3D printing  
• Applications of bioprinting and 3D printing in life sciences (examples include bio-models, medical devices, digital dentistry, implants, scaffolds, microfluidics, biosensor, microbiology, nanomaterials, drugs, cancer research and non-animal testing tissue model). 
• Regulatory barriers of 3D printing in the Life Sciences 

• Academic Researchers contemplating entry into the field  
• Experienced researchers seeking a broad picture of the field  
• Medical and healthcare practitioner aims to introduce advanced technologies for new therapeutic methodology 
• Industry Participants from Companies seeking to Understand the Technologies and Approaches 
• Investors Surveying this expanding field for investment opportunities  
• Companies of direct relevance such as medical device companies and pharmaceutical companies 
• Engineers from precision engineering and materials industries who wish to capture the value of this emerging technology  
• Regulatory specialist seeking understanding of the potentials and challenges involved in bioprinting and 3d printing in life sciences